Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
136 |
|
Actual shortage: | 34 (25%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (75%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
34 (21%) |
|
Overdue reports |
8 (24%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-ONDANSETRON | 4MG | TABLET | Resolved | 2017-10-26 | 2018-03-10 | 27164 |
MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2017-10-26 | 2017-11-22 | 27173 |
MINT-ONDANSETRON | 8MG | TABLET | Resolved | 2021-01-11 | 2021-03-23 | 131330 |
MINT-TOPIRAMATE | 25MG | TABLET | Resolved | 2024-01-29 | 2024-03-26 | 217681 |
MINT-TOPIRAMATE | 100MG | TABLET | Resolved | 2017-11-07 | 2018-01-04 | 28570 |
MINT-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2024-01-29 | 2024-07-08 | 217684 |
MINT-TOPIRAMATE | 200MG | TABLET | Actual shortage | 2024-01-29 | 2024-07-08 | 217687 |
MINT-PIOGLITAZONE | 15MG | TABLET | Resolved | 2019-07-04 | 2023-01-03 | 88502 |
MINT-PIOGLITAZONE | 30MG | TABLET | Resolved | 2019-10-09 | 2023-01-03 | 95924 |
MINT-PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-04-25 | 2023-01-03 | 113196 |
MINT-RISPERIDON | 3.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122513 |
MINT-RISPERIDON | 4.0MG | TABLET | Resolved | 2020-08-19 | 2020-09-21 | 122516 |
MINT-AMLODIPINE | 5MG | TABLET | Resolved | 2017-11-21 | 2018-01-11 | 30002 |
MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95927 |
MINT-SIMVASTATIN | 20MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95932 |
MINT-SIMVASTATIN | 40MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95935 |
MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35489 |
MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-09 | 2019-11-17 | 95938 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2019-06-04 | 2019-06-04 | 85525 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |
MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |